An estimated 1 in 127 people worldwide had autism as of 2021, according to the World Health Organization. With a global population approaching 8 billion, that translates to roughly 63 million people. But this average obscures enormous variation: some countries identify autism at far higher rates than others, and millions of people, particularly in lower-income regions, likely remain undiagnosed entirely.
Global Estimates vs. Country-Level Numbers
The WHO’s 1 in 127 figure is a global average drawn from studies across many countries, and reported prevalence varies substantially from one study to the next. Wealthier nations with robust screening programs consistently report higher rates, not necessarily because autism is more common there, but because they have the infrastructure to identify it. In the United States, the CDC’s most recent surveillance data from 2022 puts the rate at 1 in 31 children aged 8, a significant jump from the 1 in 36 figure reported just two years earlier.
Countries with fewer diagnostic resources tell a very different story. Nations like Bangladesh, Somalia, Niger, Nepal, and Haiti report rates that appear much lower, but researchers caution that these numbers reflect under-ascertainment and limited surveillance rather than a genuinely lower prevalence. When a country has few trained clinicians, limited screening programs, and competing public health priorities, many autistic people simply never receive a diagnosis. The gap between reported rates and actual rates is likely enormous in low-income settings.
Why Diagnoses Have Risen 300% in Two Decades
Autism diagnoses have increased roughly 300% over the past 20 years, a statistic that understandably raises alarm. But the increase is driven primarily by two factors that have nothing to do with autism itself becoming more common. First, the definition of autism spectrum disorder has broadened considerably, meaning more people now meet the diagnostic criteria than would have under older, narrower definitions. Second, widespread public health campaigns have pushed routine screening into standard wellness visits for children between 18 and 24 months. Parents, teachers, and pediatricians are simply better at recognizing the signs than they were a generation ago.
Greater community awareness and reduced stigma have also played a role. More families seek evaluation when they notice differences in development, and more adults are pursuing diagnosis later in life after recognizing traits they’ve carried for decades. The rising numbers reflect better detection, not a sudden surge in occurrence.
The Narrowing Gender Gap
Autism has long been considered far more common in boys and men, with historical ratios as high as 4 to 1. That gap is closing fast. A large population-based study published in The BMJ tracked birth cohorts over time and found that by 2022, the ratio of males to females diagnosed by age 20 had dropped to just 1.2 to 1. Projections from the same study suggested the ratio would reach parity by 2024.
Several factors explain why girls and women were historically underdiagnosed. Girls tend to develop stronger social and communication skills early on, which can mask autistic traits and make them harder for clinicians to spot. Many girls also “camouflage,” consciously mimicking their peers’ social behavior to fit in. Co-occurring conditions like anxiety or depression sometimes overshadow autism in clinical assessments, leading to a different diagnosis altogether. There’s also growing recognition that diagnostic tools were largely developed and validated on male populations, creating a built-in bias that missed how autism presents in women and girls.
Most Statistics Focus on Children
The vast majority of autism prevalence data comes from childhood surveillance programs, which means global estimates for autistic adults are far less precise. The CDC’s 1 in 31 figure, for example, specifically tracks 8-year-olds. Adults who grew up before widespread screening, particularly those without intellectual disability or with subtler traits, may have gone their entire lives without a formal diagnosis. This is especially true for women, people of color, and those in regions with limited mental health services.
The result is that the true global number of autistic people is almost certainly higher than any current estimate captures. Every expansion of screening criteria and every improvement in diagnostic access has pushed reported prevalence upward, and there’s no indication that process is finished.
Life Expectancy and Health Outcomes
Autism itself is not a life-threatening condition, but autistic people do face measurably shorter life expectancies. A matched cohort study from the UK found that autistic men and women without intellectual disability lived roughly 6 years fewer than their non-autistic peers. For autistic people who also had an intellectual disability, the gap was larger: about 7 years for men and nearly 15 years for women.
These differences stem from a range of co-occurring health conditions, barriers to accessing healthcare, and higher rates of mental health challenges. Autistic people without intellectual disability had 1.7 times the mortality rate of the general population, while those with intellectual disability had 2.8 times the mortality rate. The disparity is particularly stark for women with both autism and intellectual disability, a group that faces compounding disadvantages in healthcare systems that often fail to accommodate their needs.
What the Numbers Actually Mean
The short answer to “how many people have autism” is somewhere around 63 million based on current WHO estimates, but that number carries a long list of caveats. It relies on an average prevalence that smooths over vast differences between countries. It underrepresents adults, women, and people in lower-income nations. And it’s calculated from a definition of autism that continues to evolve.
What’s clear is that autism is one of the most common neurodevelopmental conditions on the planet, present in every country and every demographic group. The steady rise in reported prevalence reflects not an epidemic, but a world that is gradually getting better at recognizing a condition that has always been there.